{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:29:55Z","timestamp":1791872995652,"version":"4.3.4"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002253","name":"Netherland-America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["CX001481-07"],"award-info":[{"award-number":["CX001481-07"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K08-EY022058"],"award-info":[{"award-number":["K08-EY022058"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY025295"],"award-info":[{"award-number":["R01-EY025295"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY026877"],"award-info":[{"award-number":["P30EY026877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY030151"],"award-info":[{"award-number":["R01 EY030151"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY031952"],"award-info":[{"award-number":["R01 EY031952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY031360"],"award-info":[{"award-number":["R01EY031360"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS98950"],"award-info":[{"award-number":["R01NS98950"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vision Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.visres.2023.108317","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T07:54:03Z","timestamp":1694850843000},"page":"108317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases"],"prefix":"10.1016","volume":"213","author":[{"given":"Fabio","family":"Bigini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-1741","authenticated-orcid":false,"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7675","key":"10.1016\/j.visres.2023.108317_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"issue":"6299","key":"10.1016\/j.visres.2023.108317_b0010","doi-asserted-by":"crossref","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0015","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.visres.2023.108317_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7007-4-20","article-title":"Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma","volume":"4","author":"Anderson","year":"2006","journal-title":"BMC Biology"},{"issue":"7","key":"10.1016\/j.visres.2023.108317_b0025","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nature Biotechnology"},{"issue":"14","key":"10.1016\/j.visres.2023.108317_b0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.61.14.20","article-title":"Candidate Genetic Modifiers for RPGR Retinal Degeneration","volume":"61","author":"Appelbaum","year":"2020","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.visres.2023.108317_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2018.11.003","article-title":"Generation of gene-corrected human induced pluripotent stem cell lines derived from retinitis pigmentosa patient with Ser331Cysfs*5 mutation in MERTK","volume":"34","author":"Artero Castro","year":"2019","journal-title":"Stem Cell Research"},{"key":"10.1016\/j.visres.2023.108317_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.895713","article-title":"Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges","volume":"10","author":"Asmamaw Mengstie","year":"2022","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041855","article-title":"The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease","volume":"22","author":"A\u00edsa-Mar\u00edn","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"Suppl 5","key":"10.1016\/j.visres.2023.108317_b0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12864-017-3911-3","article-title":"eDGAR: A database of Disease-Gene Associations with annotated Relationships among genes","volume":"18","author":"Babbi","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.visres.2023.108317_b0055","doi-asserted-by":"crossref","first-page":"19969","DOI":"10.1038\/srep19969","article-title":"Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells","volume":"6","author":"Bassuk","year":"2016","journal-title":"Science Reports"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/hum.2017.048","article-title":"AAV: An Overview of Unanswered Questions","volume":"28","author":"Berns","year":"2017","journal-title":"Human Gene Therapy"},{"issue":"23","key":"10.1016\/j.visres.2023.108317_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236041","article-title":"Dead Cas Systems: Types, Principles, and Applications","volume":"20","author":"Brezgin","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0070","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-018-06448-y","article-title":"Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa","volume":"9","author":"Buskin","year":"2018","journal-title":"Nature Communications"},{"issue":"9","key":"10.1016\/j.visres.2023.108317_b0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41592-019-0508-6","article-title":"Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts","volume":"16","author":"Campa","year":"2019","journal-title":"Nature Methods"},{"key":"10.1016\/j.visres.2023.108317_b0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2156-2-18","article-title":"Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure","volume":"2","author":"Chang","year":"2001","journal-title":"BMC Genetics"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/femsre\/fuv023","article-title":"Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity","volume":"39","author":"Charpentier","year":"2015","journal-title":"FEMS Microbiology Reviews"},{"key":"10.1016\/j.visres.2023.108317_b0090","doi-asserted-by":"crossref","unstructured":"Chavez, A., Scheiman, J., Vora, S., Pruitt, B.W., Tuttle, M., E, P.R.I., Lin, S., Kiani, S., Guzman, C.D., Wiegand, D.J., Ter-Ovanesyan, D., Braff, J.L., Davidsohn, N., Housden, B.E., Perrimon, N., Weiss, R., Aach, J., Collins, J.J., & Church, G.M. (2015). Highly efficient Cas9-mediated transcriptional programming. Nat Methods, 12 (4), 326-328.","DOI":"10.1038\/nmeth.3312"},{"key":"10.1016\/j.visres.2023.108317_b0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.omtn.2022.10.012","article-title":"Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases","volume":"30","author":"Chernega","year":"2022","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"16","key":"10.1016\/j.visres.2023.108317_b0100","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.1922501117","article-title":"Mapping the cis-regulatory architecture of the human retina reveals noncoding genetic variation in disease","volume":"117","author":"Cherry","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1 suppl. 1","key":"10.1016\/j.visres.2023.108317_b0105","doi-asserted-by":"crossref","first-page":"e20190095","DOI":"10.1590\/1678-4685-gmb-2019-0095","article-title":"Maternal transmission of mitochondrial diseases","volume":"43","author":"Chiaratti","year":"2020","journal-title":"Genetics and Molecular Biology"},{"key":"10.1016\/j.visres.2023.108317_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108257","article-title":"Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases","volume":"209","author":"Chirco","year":"2023","journal-title":"Vision Research"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40135-017-0144-1","article-title":"CRISPR-mediated Ophthalmic Genome Surgery","volume":"5","author":"Cho","year":"2017","journal-title":"Curr Ophthalmol Rep"},{"issue":"8","key":"10.1016\/j.visres.2023.108317_b0120","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/IAE.0000000000002197","article-title":"CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING","volume":"38","author":"Cho","year":"2018","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.visres.2023.108317_b0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Progress in Retinal and Eye Research"},{"issue":"11","key":"10.1016\/j.visres.2023.108317_b0130","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1101\/gr.109405.110","article-title":"CRX ChIP-seq reveals the cis-regulatory architecture of mouse photoreceptors","volume":"20","author":"Corbo","year":"2010","journal-title":"Genome Research"},{"key":"10.1016\/j.visres.2023.108317_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.775330","article-title":"Prime Editing for Inherited Retinal Diseases","volume":"3","author":"da Costa","year":"2021","journal-title":"Front Genome Ed"},{"issue":"7340","key":"10.1016\/j.visres.2023.108317_b0140","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.visres.2023.108317_b0145","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1172\/JCI120429","article-title":"Gene therapy and genome surgery in the retina","volume":"128","author":"DiCarlo","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.6.3.13","article-title":"CRISPR-Cas Genome Surgery in Ophthalmology","volume":"6","author":"DiCarlo","year":"2017","journal-title":"Translational Vision Science & Technology"},{"issue":"6","key":"10.1016\/j.visres.2023.108317_b0155","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI39715","article-title":"PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome","volume":"120","author":"Ebermann","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.visres.2023.108317_b0160","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1038\/emm.2016.111","article-title":"Genome editing: The road of CRISPR\/Cas9 from bench to clinic","volume":"48","author":"Eid","year":"2016","journal-title":"Experimental & Molecular Medicine"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0165","doi-asserted-by":"crossref","first-page":"e2000315","DOI":"10.1002\/bies.202000315","article-title":"CRISPR\/Cas technology as a promising weapon to combat viral infections","volume":"43","author":"Escalona-Noguero","year":"2021","journal-title":"BioEssays"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1242\/dmm.000331","article-title":"Aberrant RNA splicing and its functional consequences in cancer cells","volume":"1","author":"Fackenthal","year":"2008","journal-title":"Disease Models & Mechanisms"},{"issue":"2","key":"10.1016\/j.visres.2023.108317_b0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/acschembio.7b00760","article-title":"Repair of a Site-Specific DNA Cleavage: Old-School Lessons for Cas9-Mediated Gene Editing","volume":"13","author":"Gallagher","year":"2018","journal-title":"ACS Chemical Biology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0180","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-020-17209-1","article-title":"High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening","volume":"11","author":"Gier","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0185","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.visres.2023.108317_b0190","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.visres.2023.108317_b0195","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1158\/0008-5472.CAN-18-0785","article-title":"CRISPR-Cas13 Precision Transcriptome Engineering in Cancer","volume":"78","author":"Granados-Riveron","year":"2018","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0200","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41556-022-00870-7","article-title":"Multiplexed genome regulation in vivo with hyper-efficient Cas12a","volume":"24","author":"Guo","year":"2022","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13059-018-1518-x","article-title":"Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR\/Cas9-mediated genome editing","volume":"19","author":"Guo","year":"2018","journal-title":"Genome Biology"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0210","doi-asserted-by":"crossref","first-page":"e1002649","DOI":"10.1371\/journal.pgen.1002649","article-title":"Transcriptional regulation of rod photoreceptor homeostasis revealed by in vivo NRL targetome analysis","volume":"8","author":"Hao","year":"2012","journal-title":"PLoS Genetics"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12033-022-00567-0","article-title":"A Review on the Mechanism and Applications of CRISPR\/Cas9\/Cas12\/Cas13\/Cas14 Proteins Utilized for Genome Engineering","volume":"65","author":"Hillary","year":"2023","journal-title":"Molecular Biotechnology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12915-022-01296-1","article-title":"Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity","volume":"20","author":"Huang","year":"2022","journal-title":"BMC Biology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13578-023-00958-z","article-title":"Comparison of DNA targeting CRISPR editors in human cells","volume":"13","author":"Huang","year":"2023","journal-title":"Cell & Bioscience"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13059-020-02193-y","article-title":"A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila","volume":"21","author":"Huynh","year":"2020","journal-title":"Genome Biology"},{"issue":"7","key":"10.1016\/j.visres.2023.108317_b0235","first-page":"1898","article-title":"Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa","volume":"41","author":"Jacobson","year":"2000","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1016\/j.visres.2023.108317_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/genes12091300","article-title":"Mitochondrial Genetic Heterogeneity in Leber's Hereditary Optic Neuropathy: Original Study with Meta-Analysis","volume":"12","author":"Jha","year":"2021","journal-title":"Genes (Basel)"},{"issue":"17","key":"10.1016\/j.visres.2023.108317_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA Base-Editing and Prime-Editing","volume":"21","author":"Kantor","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.visres.2023.108317_b0250","article-title":"CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in Rhodopsin","volume":"13 (","author":"Kaukonen","year":"2022","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/a-1057-9939","article-title":"ABCA4-Associated Stargardt Disease","volume":"237","author":"Khan","year":"2020","journal-title":"Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"},{"key":"10.1016\/j.visres.2023.108317_b0260","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0265","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","article-title":"Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.visres.2023.108317_b0270","doi-asserted-by":"crossref","first-page":"1369682","DOI":"10.1155\/2019\/1369682","article-title":"Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases","volume":"2019","author":"Kotagama","year":"2019","journal-title":"Biomed Research International"},{"issue":"6","key":"10.1016\/j.visres.2023.108317_b0275","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.devcel.2020.07.013","article-title":"CRISPR-Cas13d Induces Efficient mRNA Knockdown in Animal Embryos","volume":"54","author":"Kushawah","year":"2020","journal-title":"Developmental Cell"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0280","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/15476286.2019.1582974","article-title":"CRISPR-Cas in Streptococcus pyogenes","volume":"16","author":"Le Rhun","year":"2019","journal-title":"RNA Biology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.str.2014.10.006","article-title":"Structural Principles of CRISPR RNA Processing","volume":"23","author":"Li","year":"2015","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.visres.2023.108317_b0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41434-020-0134-z","article-title":"Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa","volume":"28","author":"Li","year":"2021","journal-title":"Gene Therapy"},{"issue":"2","key":"10.1016\/j.visres.2023.108317_b0295","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cge.12181","article-title":"Alternative splicing and retinal degeneration","volume":"84","author":"Liu","year":"2013","journal-title":"Clinical Genetics"},{"issue":"22","key":"10.1016\/j.visres.2023.108317_b0300","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1093\/nar\/gkac1192","article-title":"Improved genome editing by an engineered CRISPR-Cas12a","volume":"50","author":"Ma","year":"2022","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/j.visres.2023.108317_b0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.visres.2023.108317_b0310","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66406","article-title":"Enhanced Cas12a multi-gene regulation using a CRISPR array separator","volume":"10","author":"Magnusson","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.visres.2023.108317_b0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4939-2687-9_4","article-title":"Annotation and Classification of CRISPR-Cas Systems","volume":"1311","author":"Makarova","year":"2015","journal-title":"Methods in Molecular Biology"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0320","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1101\/gr.145441.112","article-title":"Obligate ligation-gated recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining","volume":"23","author":"Maresca","year":"2013","journal-title":"Genome Research"},{"issue":"21","key":"10.1016\/j.visres.2023.108317_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111542","article-title":"The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease","volume":"22","author":"Martinez Velazquez","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0330","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41467-020-15053-x","article-title":"Multiplexed CRISPR technologies for gene editing and transcriptional regulation","volume":"11","author":"McCarty","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10565-019-09488-2","article-title":"Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications","volume":"36","author":"Mills","year":"2020","journal-title":"Cell Biology and Toxicology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0340","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/etm.2021.10948","article-title":"Current trends in gene therapy for retinal diseases (Review)","volume":"23","author":"Moraru","year":"2022","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13073-015-0178-7","article-title":"Precision cancer mouse models through genome editing with CRISPR-Cas9","volume":"7","author":"Mou","year":"2015","journal-title":"Genome Medicine"},{"issue":"17","key":"10.1016\/j.visres.2023.108317_b0350","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1074\/jbc.RA120.012933","article-title":"CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects","volume":"295","author":"Murugan","year":"2020","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.visres.2023.108317_b0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Advanced Biomedical Research"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/13816819609057889","article-title":"Apoptosis in ocular disease: A molecular overview","volume":"17","author":"Nickells","year":"1996","journal-title":"Ophthalmic Genetics"},{"issue":"5","key":"10.1016\/j.visres.2023.108317_b0365","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.visres.2023.108317_b0370","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.preteyeres.2018.02.002","article-title":"Neuroprotective strategies for retinal disease","volume":"65","author":"Pardue","year":"2018","journal-title":"Progress in Retinal and Eye Research"},{"issue":"6","key":"10.1016\/j.visres.2023.108317_b0375","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ophtha.2018.12.050","article-title":"The Oculome Panel Test: Next-Generation Sequencing to Diagnose a Diverse Range of Genetic Developmental Eye Disorders","volume":"126","author":"Patel","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0380","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bj.2019.10.005","article-title":"CRISPR-Cas12a: Functional overview and applications","volume":"43","author":"Paul","year":"2020","journal-title":"Biomedical Journal"},{"issue":"15","key":"10.1016\/j.visres.2023.108317_b0385","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0390","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41592-019-0347-5","article-title":"Spotlight on Cas12","volume":"16","author":"Rusk","year":"2019","journal-title":"Nature Methods"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0395","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yexcr.2014.03.012","article-title":"Mitochondrial DNA disease-molecular insights and potential routes to a cure","volume":"325","author":"Russell","year":"2014","journal-title":"Experimental Cell Research"},{"issue":"9","key":"10.1016\/j.visres.2023.108317_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091842","article-title":"Non-Viral Delivery of CRISPR\/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations","volume":"14","author":"Salman","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0405","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.1038\/s41598-021-98965-y","article-title":"Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair","volume":"11","author":"Schubert","year":"2021","journal-title":"Science Reports"},{"key":"10.1016\/j.visres.2023.108317_b0410","doi-asserted-by":"crossref","unstructured":"Sepah, Y.J., Velez, G., Tang, P.H., Yang, J., Chemudupati, T., Li, A.S., Nguyen, Q.D., Bassuk, A.G., & Mahajan, V.B. (2020). Proteomic analysis of intermediate uveitis suggests myeloid cell recruitment and implicates IL-23 as a therapeutic target. In: Am J Ophthalmol Case Rep, 18 (p. 100646). United States: \u00a9 2020 The Authors.","DOI":"10.1016\/j.ajoc.2020.100646"},{"issue":"11","key":"10.1016\/j.visres.2023.108317_b0415","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tibs.2015.08.006","article-title":"Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?","volume":"40","author":"Sfeir","year":"2015","journal-title":"Trends in Biochemical Sciences"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0420","doi-asserted-by":"crossref","first-page":"371","DOI":"10.34172\/bi.2022.23871","article-title":"Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems","volume":"12","author":"Shams","year":"2022","journal-title":"BioImpacts: BI"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0425","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2016.12.023","article-title":"Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28","volume":"65","author":"Smargon","year":"2017","journal-title":"Molecular Cell"},{"issue":"2","key":"10.1016\/j.visres.2023.108317_b0430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/eye.2016.295","article-title":"Assessing retinal ganglion cell damage","volume":"31","author":"Smith","year":"2017","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.visres.2023.108317_b0435","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.molcel.2018.06.043","article-title":"Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a","volume":"71","author":"Strohkendl","year":"2018","journal-title":"Molecular Cell"},{"issue":"39","key":"10.1016\/j.visres.2023.108317_b0440","article-title":"Precision genome editing in the eye","volume":"119","author":"Suh","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.visres.2023.108317_b0445","unstructured":"Suhani, V., Jenny, C., Ru, X., Nathan, J.V., Luis, Q., William, T.P., Luk, H.V., Alejandro, C., & George, C. (2018). Rational design of a compact CRISPR-Cas9 activator for AAV-mediated delivery. bioRxiv, 298620."},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.15-17841","article-title":"Apoptotic Retinal Ganglion Cell Death After Optic Nerve Transection or Crush in Mice: Delayed RGC Loss With BDNF or a Caspase 3 Inhibitor","volume":"57","author":"S\u00e1nchez-Migall\u00f3n","year":"2016","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.visres.2023.108317_b0455","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.677587","article-title":"Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications","volume":"9","author":"Tang","year":"2021","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0460","article-title":"Applications of CRISPR-Cas9 as an Advanced Genome Editing System in Life Sciences","volume":"10","author":"Tavakoli","year":"2021","journal-title":"BioTech (Basel)"},{"key":"10.1016\/j.visres.2023.108317_b0465","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41421-018-0069-3","article-title":"Repurposing CRISPR-Cas12b for mammalian genome engineering","volume":"4","author":"Teng","year":"2018","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0470","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41587-022-01419-7","article-title":"High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects","volume":"41","author":"Tong","year":"2023","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.visres.2023.108317_b0475","doi-asserted-by":"crossref","unstructured":"Toral, M.A., Charlesworth, C.T., Ng, B., Chemudupati, T., Homma, S., Nakauchi, H., Bassuk, A.G., Porteus, M.H., & Mahajan, V.B. (2022). Author Correction: Investigation of Cas9 antibodies in the human eye. In: Nat Commun, 13 (p. 2109). England.","DOI":"10.1038\/s41467-022-29844-x"},{"key":"10.1016\/j.visres.2023.108317_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108330","article-title":"USH2A-retinopathy: From genetics to therapeutics","volume":"201","author":"Toualbi","year":"2020","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.visres.2023.108317_b0485","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcell.2018.00088","article-title":"Multiplexed CRISPR\/Cas9 Targeting of Genes Implicated in Retinal Regeneration and Degeneration","volume":"6","author":"Unal Eroglu","year":"2018","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0490","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jamaophthalmol.2015.5934","article-title":"Precision Medicine: Personalized Proteomics for the Diagnosis and Treatment of Idiopathic Inflammatory Disease","volume":"134","author":"Velez","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.visres.2023.108317_b0495","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/joim.13046","article-title":"Strategies for fighting mitochondrial diseases","volume":"287","author":"Viscomi","year":"2020","journal-title":"Journal of Internal Medicine"},{"issue":"Suppl 1","key":"10.1016\/j.visres.2023.108317_b0500","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.eye.6702880","article-title":"The neurobiology of cell death in glaucoma","volume":"21","author":"Vrabec","year":"2007","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.visres.2023.108317_b0505","article-title":"CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells","volume":"9","author":"Wang","year":"2021","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0510","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.visres.2023.108317_b0515","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/jcmm.15039","article-title":"The rapidly advancing Class 2 CRISPR-Cas technologies: A customizable toolbox for molecular manipulations","volume":"24","author":"Wang","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"7","key":"10.1016\/j.visres.2023.108317_b0520","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1093\/nar\/gkad165","article-title":"Precise homology-directed installation of large genomic edits in human cells with cleaving and nicking high-specificity Cas9 variants","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"10.1016\/j.visres.2023.108317_b0525","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13040262","article-title":"The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons","volume":"13","author":"Wu","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10.1016\/j.visres.2023.108317_b0530","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/mt.2016.107","article-title":"CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa","volume":"24","author":"Wu","year":"2016","journal-title":"Molecular Therapy"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0535","doi-asserted-by":"crossref","DOI":"10.3390\/v11010028","article-title":"Viral Delivery Systems for CRISPR","volume":"11","author":"Xu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.visres.2023.108317_b0540","article-title":"Grand Challenges in Ocular Inflammatory Diseases. Frontiers","volume":"2","author":"Xu","year":"2022","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.visres.2023.108317_b0545","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","article-title":"Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing","volume":"81","author":"Xu","year":"2021","journal-title":"Molecular Cell"},{"issue":"3","key":"10.1016\/j.visres.2023.108317_b0550","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0555","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13059-023-02852-w","article-title":"Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme","volume":"24","author":"Zhan","year":"2023","journal-title":"Genome Biology"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0560","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/s41467-019-10507-3","article-title":"Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d","volume":"10","author":"Zhang","year":"2019","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.visres.2023.108317_b0565","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cell.2018.09.001","article-title":"Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d","volume":"175","author":"Zhang","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.visres.2023.108317_b0570","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target Effects in CRISPR\/Cas9-mediated Genome Engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Molecular Therapy - Nucleic Acids"}],"container-title":["Vision Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042698923001414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042698923001414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:58:23Z","timestamp":1762221503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042698923001414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":114,"alternative-id":["S0042698923001414"],"URL":"https:\/\/doi.org\/10.1016\/j.visres.2023.108317","relation":{},"ISSN":["0042-6989"],"issn-type":[{"value":"0042-6989","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases","name":"articletitle","label":"Article Title"},{"value":"Vision Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.visres.2023.108317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108317"}}